Header Logo

Connection

PRIYADHARSINI NAGARAJAN to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications PRIYADHARSINI NAGARAJAN has written about Clinical Trials, Phase I as Topic.
PRIYADHARSINI NAGARAJAN
Connection Strength
0.031
Clinical Trials, Phase I as Topic
  1. Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumor. J Cutan Pathol. 2018 Oct; 45(10):786-790.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.